IFNG and neoplasm: Although cytokines like Interferon alpha (IFN-α) and Interferon gamma (IFN-γ) theoretically bolster the cytotoxicity of T cells against tumors (20), their therapeutic efficacy in clinical trials has been limited (21), indicating that cytokine function can also be dysregulated in the tumor microenvironment.